Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Chapman

Showing results (881-890 of 891) with videos related to

Pageof 90
Sort By:
Plos One|April 7, 2016
Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic ReleaseAristos J Alexandrou, Adam R Brown, Mark L Chapman, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivativesMichael E Kort, Robert N Atkinson, James B Thomas, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic painIrene Drizin, Robert J Gregg, Marc J C Scanio, et al.
Journal of Medicinal Chemistry|January 8, 2008
Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory painMichael E Kort, Irene Drizin, Robert J Gregg, et al.
Psychotherapy and Psychosomatics|October 24, 2025
Treatment Moderators of Symptom Severity in Psychotherapy for People with Borderline Personality Disorder: Systematic Review with Meta-Analyses of Individual Participant DataJohanne Pereira Ribeiro, Jutta Stoffers-Winterling, Mie Sedoc Jørgensen, et al.
Free Radical Biology & Medicine|July 22, 2010
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosisEline Thomson, Siobhain Brennan, Revathy Senthilmohan, et al.
Journal of Medicinal Chemistry|April 28, 2022
Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational PlatformHaifeng Tang, Kristian Jensen, Evelyne Houang, et al.
Journal of Medicinal Chemistry|July 7, 2017
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.
Science Translational Medicine|July 15, 2021
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancerStelios Chrysostomou, Rajat Roy, Filippo Prischi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 16, 2020
Commentaries on Point:Counterpoint: Investigators should/should not control for menstrual cycle phase when performing studies of vascular controlGabrielle E W Giersch, Nisha Charkoudian, T Pereira, et al.
Pageof 90

Showing results (881-890 of 891) with videos related to

Sort By:
Pageof 90
Plos One|April 7, 2016
Subtype-Selective Small Molecule Inhibitors Reveal a Fundamental Role for Nav1.7 in Nociceptor Electrogenesis, Axonal Conduction and Presynaptic ReleaseAristos J Alexandrou, Adam R Brown, Mark L Chapman, et al.
Bioorganic & Medicinal Chemistry Letters|September 22, 2010
Subtype-selective Na(v)1.8 sodium channel blockers: identification of potent, orally active nicotinamide derivativesMichael E Kort, Robert N Atkinson, James B Thomas, et al.
Bioorganic & Medicinal Chemistry|May 27, 2008
Discovery of potent furan piperazine sodium channel blockers for treatment of neuropathic painIrene Drizin, Robert J Gregg, Marc J C Scanio, et al.
Journal of Medicinal Chemistry|January 8, 2008
Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory painMichael E Kort, Irene Drizin, Robert J Gregg, et al.
Psychotherapy and Psychosomatics|October 24, 2025
Treatment Moderators of Symptom Severity in Psychotherapy for People with Borderline Personality Disorder: Systematic Review with Meta-Analyses of Individual Participant DataJohanne Pereira Ribeiro, Jutta Stoffers-Winterling, Mie Sedoc Jørgensen, et al.
Free Radical Biology & Medicine|July 22, 2010
Identifying peroxidases and their oxidants in the early pathology of cystic fibrosisEline Thomson, Siobhain Brennan, Revathy Senthilmohan, et al.
Journal of Medicinal Chemistry|April 28, 2022
Discovery of a Novel Class of d-Amino Acid Oxidase Inhibitors Using the Schrödinger Computational PlatformHaifeng Tang, Kristian Jensen, Evelyne Houang, et al.
Journal of Medicinal Chemistry|July 7, 2017
Discovery of Clinical Candidate 4-[2-(5-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide (PF-05089771): Design and Optimization of Diaryl Ether Aryl Sulfonamides as Selective Inhibitors of Na<sub>V</sub>1.7Nigel A Swain, Dave Batchelor, Serge Beaudoin, et al.
Science Translational Medicine|July 15, 2021
Repurposed floxacins targeting RSK4 prevent chemoresistance and metastasis in lung and bladder cancerStelios Chrysostomou, Rajat Roy, Filippo Prischi, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|November 16, 2020
Commentaries on Point:Counterpoint: Investigators should/should not control for menstrual cycle phase when performing studies of vascular controlGabrielle E W Giersch, Nisha Charkoudian, T Pereira, et al.
Pageof 90